E M Mowry1, D Pelletier2, Z Gao3, M D Howell3, S S Zamvil4, E Waubant4. 1. Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Neurology, Yale University School of Medicine, New Haven, CT, USA. 3. Immune Tolerance Network, Bethesda, MD, USA. 4. Neurology, University of California, San Francisco, San Francisco, CA, USA.
Abstract
BACKGROUND AND PURPOSE: Vitamin D status has been associated with inflammatory activity in multiple sclerosis (MS), but it is not known if it is associated with gray matter volume, the loss of which predicts long-term disability in MS. The association of vitamin D levels with brain volume measures and inflammatory activity in patients with clinically isolated syndrome (CIS) was investigated. METHODS: In the phase 2 CIS trial of atorvastatin, 25-hydroxyvitamin D levels were evaluated for their age-adjusted associations with normalized gray matter and brain parenchymal volumes on brain magnetic resonance imaging (MRI). The relationships between 25-hydroxyvitamin D levels and clinical and MRI measures of inflammatory activity were also assessed. RESULTS: In 65 patients in this substudy, each 25 nmol/l higher 25-hydroxyvitamin D level was associated with 7.8 ml higher gray matter volume (95% confidence interval 1.0, 14.6, P = 0.025). There was a tendency for an inverse association of average 25-hydroxyvitamin D levels and the composite end-point of ≥3 new brain T2 lesions or ≥1 relapse within a year (odds ratio per 25 nmol/l higher 25-hydroxyvitamin D level 0.66, 95% confidence interval 0.41, 1.08, P = 0.096). CONCLUSIONS: Vitamin D status may impact neurodegeneration after CIS, although these results should be replicated in a second study. If confirmed in clinical trials, vitamin D supplementation may reduce long-term disability.
BACKGROUND AND PURPOSE:Vitamin D status has been associated with inflammatory activity in multiple sclerosis (MS), but it is not known if it is associated with gray matter volume, the loss of which predicts long-term disability in MS. The association of vitamin D levels with brain volume measures and inflammatory activity in patients with clinically isolated syndrome (CIS) was investigated. METHODS: In the phase 2 CIS trial of atorvastatin, 25-hydroxyvitamin D levels were evaluated for their age-adjusted associations with normalized gray matter and brain parenchymal volumes on brain magnetic resonance imaging (MRI). The relationships between 25-hydroxyvitamin D levels and clinical and MRI measures of inflammatory activity were also assessed. RESULTS: In 65 patients in this substudy, each 25 nmol/l higher 25-hydroxyvitamin D level was associated with 7.8 ml higher gray matter volume (95% confidence interval 1.0, 14.6, P = 0.025). There was a tendency for an inverse association of average 25-hydroxyvitamin D levels and the composite end-point of ≥3 new brain T2 lesions or ≥1 relapse within a year (odds ratio per 25 nmol/l higher 25-hydroxyvitamin D level 0.66, 95% confidence interval 0.41, 1.08, P = 0.096). CONCLUSIONS:Vitamin D status may impact neurodegeneration after CIS, although these results should be replicated in a second study. If confirmed in clinical trials, vitamin D supplementation may reduce long-term disability.
Authors: Jennifer S Graves; Lisa F Barcellos; Lauren Krupp; Anita Belman; Xiaorong Shao; Hong Quach; Janace Hart; Tanuja Chitnis; Bianca Weinstock-Guttman; Gregory Aaen; Leslie Benson; Mark Gorman; Benjamin Greenberg; Timothy Lotze; Mar Soe; Jayne Ness; Moses Rodriguez; John Rose; Teri Schreiner; Jan-Mendelt Tillema; Amy Waldman; T Charles Casper; Emmanuelle Waubant Journal: Mult Scler Date: 2019-05-13 Impact factor: 6.312
Authors: Ellen M Mowry; Christina J Azevedo; Charles E McCulloch; Darin T Okuda; Robin R Lincoln; Emmanuelle Waubant; Stephen L Hauser; Daniel Pelletier Journal: Neurology Date: 2018-11-14 Impact factor: 11.800
Authors: Prue H Hart; Robyn M Lucas; David R Booth; William M Carroll; David Nolan; Judith M Cole; Anderson P Jones; Allan G Kermode Journal: Front Immunol Date: 2017-01-24 Impact factor: 7.561
Authors: Akiah Ottesen Berg; Kjetil N Jørgensen; Mari Nerhus; Lavinia Athanasiu; Alice B Popejoy; Francesco Bettella; Linn Christin Bonaventure Norbom; Tiril P Gurholt; Sandra R Dahl; Ole A Andreassen; Srdjan Djurovic; Ingrid Agartz; Ingrid Melle Journal: PLoS One Date: 2018-08-24 Impact factor: 3.240
Authors: Radha Ayyagari; Yii-der I Chen; Linda M Zangwill; Matt Holman; Keri Dirkes; Yang Hai; Zorayr Arzumanyan; Rigby Slight; Naama Hammel; Christopher A Girkin; Jeffrey M Liebmann; Robert Feldman; Harvey Dubiner; Kent D Taylor; Jerome I Rotter; Xiuqing Guo; Robert N Weinreb Journal: Mol Vis Date: 2019-08-09 Impact factor: 2.367